(Q46130423)

19 December 2017

title

Consideration of individual bioequivalence (English)

1 reference

19 December 2017

author name string

S Anderson

series ordinal

1

1 reference

19 December 2017

W W Hauck

series ordinal

2

1 reference

19 December 2017

publication date

1 June 1990

1 reference

19 December 2017

Journal of Pharmacokinetics and Pharmacodynamics

published in

1 reference

19 December 2017

volume

18

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

259-273

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/bf01062202

exact match

0 references

cites work

Statistical Aspects of Comparative Bioavailability Trials

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01062202

Statistical simulation study of new proposed uniformity requirement for bioequivalency studies.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01062202

A new statistical procedure for testing equivalence in two-group comparative bioavailability trials

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01062202

Assessment of 75/75 rule: FDA viewpoint

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2380920

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2380920

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF01062202

1 reference

19 December 2017

PubMed ID

2380920

1 reference

19 December 2017